• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中,黑质中黑色素化神经元胞体上[125I] -转铁蛋白结合位点的密度降低。

The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.

作者信息

Faucheux B A, Hauw J J, Agid Y, Hirsch E C

机构信息

INSERM U289, Hôpital de la Salpêtrière, Paris, France.

出版信息

Brain Res. 1997 Feb 21;749(1):170-4. doi: 10.1016/s0006-8993(96)01412-6.

DOI:10.1016/s0006-8993(96)01412-6
PMID:9070646
Abstract

The density of [125I]-diferric-transferrin binding sites was investigated at the cellular level on melanized neurons located in the mesencephalon of patients with Parkinson's disease and control subjects, using quantitative autoradiography of in vitro incubated brain sections. In parkinsonian patients mean densities were reduced, the difference being statistically significant for the ventral tier of the substantia nigra, which is the subregion most affected by neuronal death in the disease. The absence of increase in the number of transferrin receptors on the perikarya within a population of neurons accumulating iron probably reflects the post-transcriptional gene regulation of the number of transferrin receptors that depends upon iron content in eukaryote cells.

摘要

利用体外孵育脑切片的定量放射自显影技术,在细胞水平上研究了帕金森病患者和对照受试者中脑黑素化神经元上[125I] - 二价铁转铁蛋白结合位点的密度。帕金森病患者的平均密度降低,黑质腹侧层的差异具有统计学意义,黑质腹侧层是该疾病中受神经元死亡影响最严重的亚区域。在积累铁的神经元群体中,其胞体上转铁蛋白受体数量没有增加,这可能反映了真核细胞中转铁蛋白受体数量的转录后基因调控取决于铁含量。

相似文献

1
The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.帕金森病中,黑质中黑色素化神经元胞体上[125I] -转铁蛋白结合位点的密度降低。
Brain Res. 1997 Feb 21;749(1):170-4. doi: 10.1016/s0006-8993(96)01412-6.
2
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.125I-转铁蛋白结合位点在对照组和帕金森病患者中脑的分布。
J Neurochem. 1993 Jun;60(6):2338-41. doi: 10.1111/j.1471-4159.1993.tb03527.x.
3
Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.对照组和帕金森病患者中脑单胺囊泡摄取位点的区域分布:一项使用氚标记丁苯那嗪的尸检研究
Brain Res. 1995 Sep 18;692(1-2):233-43. doi: 10.1016/0006-8993(95)00674-f.
4
Transferrin receptors in the parkinsonian midbrain.帕金森病中脑的转铁蛋白受体
Neuropathol Appl Neurobiol. 1994 Oct;20(5):468-72. doi: 10.1111/j.1365-2990.1994.tb00997.x.
5
Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain.对照和帕金森病大脑黑质及黑质旁核中表达神经降压素受体信使核糖核酸的黑素化神经元的异质性
Neuroscience. 1995 Jan;64(2):405-17. doi: 10.1016/0306-4522(94)00395-l.
6
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?帕金森病患者中脑内M-钙蛋白酶表达增加,但在其他累及中脑的神经退行性疾病中未出现这种情况:其在神经细胞死亡中起作用吗?
Neuroscience. 1996 Aug;73(4):979-87. doi: 10.1016/0306-4522(96)00100-5.
7
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.帕金森病黑质中脑源性神经营养因子蛋白表达降低。
Neuroreport. 1999 Feb 25;10(3):557-61. doi: 10.1097/00001756-199902250-00021.
8
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.在对照受试者以及帕金森病和阿尔茨海默病患者的中脑中,对细胞水平的酪氨酸羟化酶进行免疫细胞化学定量分析。
J Neurochem. 1993 Sep;61(3):1024-34. doi: 10.1111/j.1471-4159.1993.tb03616.x.
9
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.
Neuroscience. 1990;38(1):245-53. doi: 10.1016/0306-4522(90)90389-l.
10
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.铁蛋白上调缺乏与帕金森病患者黑质中铁调节蛋白-1的持续结合活性相关。
J Neurochem. 2002 Oct;83(2):320-30. doi: 10.1046/j.1471-4159.2002.01118.x.

引用本文的文献

1
Nigrostriatal iron accumulation in the progression of Parkinson's disease.帕金森病进展过程中黑质纹状体铁蓄积
NPJ Parkinsons Dis. 2025 Apr 11;11(1):72. doi: 10.1038/s41531-025-00911-6.
2
Brain-Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha-Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease.脑靶向脂质体负载单克隆抗体可减少 α-突触核蛋白聚集并改善帕金森病的行为症状。
Adv Mater. 2023 Dec;35(51):e2304654. doi: 10.1002/adma.202304654. Epub 2023 Oct 27.
3
Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
LRRK2 基因突变与帕金森病相关,将 Rab8a 隔离到受损的溶酶体中,并调节小胶质细胞中转铁蛋白介导的铁摄取。
PLoS Biol. 2021 Dec 16;19(12):e3001480. doi: 10.1371/journal.pbio.3001480. eCollection 2021 Dec.
4
S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.二价金属转运蛋白 1 的 S-亚硝基化增强铁摄取以介导多巴胺能神经元丢失和运动功能障碍。
J Neurosci. 2018 Sep 26;38(39):8364-8377. doi: 10.1523/JNEUROSCI.3262-17.2018. Epub 2018 Aug 13.
5
Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.帕金森病患者铁代谢及其 MRI 检测:系统综述。
Neurol Sci. 2017 Dec;38(12):2095-2101. doi: 10.1007/s10072-017-3099-y. Epub 2017 Sep 2.
6
Brain Iron Metabolism Dysfunction in Parkinson's Disease.帕金森病中的脑铁代谢功能障碍。
Mol Neurobiol. 2017 May;54(4):3078-3101. doi: 10.1007/s12035-016-9879-1. Epub 2016 Apr 2.
7
Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.黑质铁含量升高是帕金森病的一个恒定特征,并且是神经退行性变的一个充分原因。
Biomed Res Int. 2014;2014:581256. doi: 10.1155/2014/581256. Epub 2014 Jan 16.
8
A delicate balance: Iron metabolism and diseases of the brain.微妙的平衡:铁代谢与脑部疾病。
Front Aging Neurosci. 2013 Jul 18;5:34. doi: 10.3389/fnagi.2013.00034. eCollection 2013.
9
Chelators in the treatment of iron accumulation in Parkinson's disease.螯合剂在帕金森病铁蓄积治疗中的应用
Int J Cell Biol. 2012;2012:983245. doi: 10.1155/2012/983245. Epub 2012 Jun 13.
10
1B/(-)IRE DMT1 expression during brain ischemia contributes to cell death mediated by NF-κB/RelA acetylation at Lys310.脑缺血时 1B/(-)IRE DMT1 的表达导致 NF-κB/RelA 在 Lys310 乙酰化介导的细胞死亡。
PLoS One. 2012;7(5):e38019. doi: 10.1371/journal.pone.0038019. Epub 2012 May 29.